Incepta to produce Sinopharm Covid-19 vaccine.

Sinopharm’s Covid-19 will be produced by Incepta, leader of Bangladesh medical sector.

The contract signed by the two companies and both governments as well, is setting a goal of 5 million vaccines per month.

This agreement proves once again the capability of Bangladeshi’s pharmaceutical industry, and its role in the country’s development of value-added products.

https://news.cgtn.com/news/2021-08-17/Sinopharm-signs-with-Bangladesh-to-jointly-produce-COVID-19-vaccines-12NYzGfA8r6/index.html 

https://www.dhakatribune.com/bangladesh/2021/08/16/vaccine-co-production-bangladesh-signs-mou-with-sinopharm-incepta